As of 2025-07-07, the Intrinsic Value of Mouwasat Medical Services Company SJSC (4002.SR) is 38.71 SAR. This 4002.SR valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 76.25 SAR, the upside of Mouwasat Medical Services Company SJSC is -49.20%.
The range of the Intrinsic Value is 33.07 - 46.97 SAR
Based on its market price of 76.25 SAR and our intrinsic valuation, Mouwasat Medical Services Company SJSC (4002.SR) is overvalued by 49.20%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 33.07 - 46.97 | 38.71 | -49.2% |
| DCF (Growth 10y) | 42.83 - 59.09 | 49.50 | -35.1% |
| DCF (EBITDA 5y) | 68.38 - 93.98 | 81.61 | 7.0% |
| DCF (EBITDA 10y) | 68.77 - 97.26 | 82.70 | 8.5% |
| Fair Value | 31.21 - 31.21 | 31.21 | -59.07% |
| P/E | 55.04 - 79.72 | 69.90 | -8.3% |
| EV/EBITDA | 52.01 - 75.29 | 66.56 | -12.7% |
| EPV | 19.31 - 23.28 | 21.30 | -72.1% |
| DDM - Stable | 16.52 - 31.15 | 23.83 | -68.7% |
| DDM - Multi | 27.39 - 40.69 | 32.79 | -57.0% |
| Market Cap (mil) | 15,250.00 |
| Beta | 1.24 |
| Outstanding shares (mil) | 200.00 |
| Enterprise Value (mil) | 15,462.93 |
| Market risk premium | 6.13% |
| Cost of Equity | 13.96% |
| Cost of Debt | 5.00% |
| WACC | 13.52% |